114 results on '"Jimenez-Navarro, Manuel"'
Search Results
2. Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients
3. Cancer in patients with heart failure: Incidence, risk factors and prognostic impact
4. Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations
5. Quality of Life After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement
6. Novel Fibrillar and Non-Fibrillar Collagens Involved in Fibrotic Scar Formation after Myocardial Infarction.
7. Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics
8. Role of epicardial adipose tissue NPR-C in acute coronary syndrome
9. Impact of Percutaneous Coronary Revascularization of Severe Coronary Lesions on Secondary Branches
10. Usefulness of Genetic Study by Next-generation Sequencing in High-risk Arrhythmogenic Cardiomyopathy
11. The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome.
12. Long-term Follow-up of Patients With Severe Aortic Stenosis Treated With a Self-expanding Prosthesis
13. Prognostic value of body mass index in transcatheter aortic valve implantation: A “J”-shaped curve
14. Clinical and echocardiographic course in takotsubo cardiomyopathy: Longterm followup from a multicenter study
15. Cardioprotective Effect of Ranolazine in the Process of Ischemia-reperfusion in Adult Rat Cardiomyocytes
16. Immediate and Long-Term Results of Drug-Eluting Stents in Mammary Artery Grafts
17. Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2
18. Comparison of Paclitaxel and Everolimus-eluting Stents in ST-segment Elevation Myocardial Infarction and Influence of Thrombectomy on Outcomes. ESTROFA-IM Study
19. Prognostic Value of Fractional Flow Reserve: Linking Physiologic Severity to Clinical Outcomes
20. Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction
21. Clinical Impact of Intravascular Ultrasound Guidance in Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Disease: Pooled Analysis at the Patient-Level of 4 Registries
22. Hereditary patterns of bicuspid aortic valve in a hundred families
23. Percutaneous Implantation of the CoreValve® Self-expanding Valve Prosthesis in Patients With Severe Aortic Stenosis and Porcelain Aorta: Medium-term Follow-up
24. Comparison of Paclitaxel-Eluting Stents (Taxus) and Everolimus-Eluting Stents (Xience) in Left Main Coronary Artery Disease With 3 Years Follow-Up (from the ESTROFA-LM Registry)
25. Factors Predicting and Having an Impact on the Need for a Permanent Pacemaker After CoreValve Prosthesis Implantation Using the New Accutrak Delivery Catheter System
26. Differences in Outcome of Heart Failure With Preserved or Depressed Systolic Function in Patients Older Than 70 Years Who Receive Beta Blockers
27. Coronary Disease Extension Determines Mobilization of Endothelial Progenitor Cells and Cytokines After a First Myocardial Infarction With ST Elevation
28. Aldosterone Receptor Antagonist Use After Myocardial Infarction. Data From the REICIAM Registry
29. Performance of Glycated Hemoglobin and a Risk Model for Detection of Unknown Diabetes in Coronary Patients
30. Percutaneous Treatment of a Dysfunctional Aortic Bioprosthesis With the CoreValve ® Prosthesis
31. Changes in Atrioventricular Conduction and Predictors of Pacemaker Need After Percutaneous Implantation of the CoreValve ® Aortic Valve Prosthesis
32. Effect of a Training Program for Primary Care Physicians on the Optimization of Beta-Blocker Treatment in Elderly Patients With Heart Failure
33. Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention
34. Comparison of Medium-Term Outcomes Obtained With Drug-Eluting Stents and Coronary Artery Bypass Grafts in an Unselected Population of Diabetic Patients With Multivessel Coronary Disease. Propensity Score Analysis
35. Prevalence of Heart Failure in the Spanish General Population Aged Over 45 Years. The PRICE Study
36. Long-Term Prognosis in Diabetic Patients in Whom Revascularization Is Deferred Following Fractional Flow Reserve Assessment
37. Sex differences in plasma fractalkine (CX3CL1) levels in rats exposed to early stress and alcohal
38. How Many Patients Admitted for Heart Failure Are Eligible for Cardiac Resynchronization Therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) Study
39. Influence of high homocysteine and low folate plasmatic levels in medium-term prognosis after acute coronary syndromes
40. Comments on the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy
41. Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension
42. Comments on the 2018 ESC/EACTS Guidelines for Myocardial Revascularization
43. Comments on the 2018 ESC Fourth Universal Definition of Myocardial Infarction
44. Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy
45. Dynamic left ventricular obstruction evoked by exercise: importance of outflow tract size
46. Transcatheter Closure of Aorto-Left Atrial Fistula Using an Amplatzer Device
47. Collagen Synthesis and Heart Failure
48. Systolic Ventricular Dysfunction, a New Marker of Coronary Artery Disease in Patients With Aortic Stenosis Without Previous Myocardial Infarction
49. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure
50. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.